Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Xiao-Wen Zhang
Xin-Lin Zhang
Biao Xu
Li-Na Kang
机构：
[1] Nanjing University School of Medicine,Department of Endocrinology, Affiliated Drum Tower Hospital
[2] Nanjing University School of Medicine,Department of Cardiology, Affiliated Drum Tower Hospital
来源：
Acta Diabetologica | 2018年 / 55卷
关键词：
Insulin degludec; Insulin glargine; Hypoglycemia; Meta-analysis; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 441
页数：12
相关论文
共 50 条
  • [1] Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials
    Zhang, Xiao-Wen
    Zhang, Xin-Lin
    Xu, Biao
    Kang, Li-Na
    ACTA DIABETOLOGICA, 2018, 55 (05) : 429 - 441
  • [2] Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials
    Long, Tao
    Lin, Jin-ting
    Lin, Min-hua
    Wu, Qian-long
    Lai, Jian-mei
    Li, Sheng-zhen
    Zhou, Zi-chao
    Zeng, Ji-yuan
    Huang, Jia-shuan
    Zeng, Chun-ping
    Lai, Yao-ming
    ENDOCRINE JOURNAL, 2022, 69 (08) : 959 - 969
  • [3] Local tolerability of insulin degludec is comparable to insulin glargine: a meta-analysis of trials in type 1 and type 2 diabetes
    Meneghini, L. F.
    Schumm-Draeger, P. -M.
    Harris, S.
    Gall, M. -A.
    Lassota, N.
    Christiansen, J. S.
    DIABETOLOGIA, 2012, 55 : S380 - S380
  • [4] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
  • [5] Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials
    Bazzano, L. A.
    Lee, L. J.
    Shi, L.
    Reynolds, K.
    Jackson, J. A.
    Fonseca, V.
    DIABETIC MEDICINE, 2008, 25 (08) : 924 - 932
  • [6] Efficacy and Safety of Insulin Degludec/Insulin Aspart versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
    Niu, Yan-Li
    Zhang, Ye
    Song, Zhi-Yong
    Zhao, Chuan-Zhi
    Luo, Yun
    Wang, Yan
    Yuan, Jing
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2024, 53 (02) : 313 - 322
  • [7] Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Alhmoud, Eman N.
    Saad, Mohamed Omar
    Omar, Nabil Elhadi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [8] Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
    Vora, Jiten
    Christensen, Torsten
    Rana, Azhar
    Bain, Steve C.
    DIABETES THERAPY, 2014, 5 (02) : 435 - 446
  • [9] Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
    Jiten Vora
    Torsten Christensen
    Azhar Rana
    Steve C. Bain
    Diabetes Therapy, 2014, 5 : 435 - 446
  • [10] Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
    Sylvie Erpeldinger
    Michaela B. Rehman
    Christophe Berkhout
    Christophe Pigache
    Yves Zerbib
    Francis Regnault
    Emilie Guérin
    Irène Supper
    Catherine Cornu
    Behrouz Kassaï
    François Gueyffier
    Rémy Boussageon
    BMC Endocrine Disorders, 16
12345